Oct. 07, 2020
The Nobel Prize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for genome editing that relates to CRISPR-Cas3 technology owned by C4U.
Oct. 14-16, 2020
Participate BIO JAPAN at Yokohama Pacifico (JHVS booth V-51).
Please drop by our booth!
Sep. 21, 2020
A novel CRISPR diagnostic, named "CONAN" method, developed by Prof. Tomoji Mashimo, was featured in the Asahi Shinbun.
Aug. 11, 2020
Dr. Tomoji Mashimo and Mr. Akimitsu Hirai were added into the board members in the extraordinary meeting of shareholders, and Mr. Hirai was inaugurated as a president and CEO.
July 02, 2020
The paper was published in Human Genetics.
June 03, 2020
The paper was published in medrxiv.
May 25, 2020
Feb. 03, 2020
Akira Uotani has been appointed as the new CEO.